GADD45B Polyclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0475073
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $472.65
About this award
The University of Virginia awarded contract A207_PO-0475073 to Life Technologies Corporation on August 31, 2026, for the procurement of laboratory reagents. The prime contractor will deliver one unit of GADD45B Polyclonal Antibody to Josh Donovan at an awarded value of $472.65. GADD45B (Growth Arrest and DNA-Damage-inducible 45 Beta) Polyclonal Antibody is a research-grade immunological reagent commonly utilized in molecular biology and immunological research applications.
This procurement represents a single-item acquisition by the University of Virginia, a Virginia-based higher education institution. The contract value of approximately $473 indicates a limited-scope purchase typical of incremental laboratory supply orders. No extended performance period is specified in the award documentation, suggesting delivery is expected to occur promptly following order placement. Life Technologies Corporation, a leading life sciences reagent supplier, was selected as the prime contractor for this straightforward goods delivery.
Line items
| Item | Total |
|---|---|
| GADD45B Polyclonal Antibody | $472.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0475073?
Contract A207_PO-0475073 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 31, 2026.
How much is contract A207_PO-0475073 worth?
Its cumulative value is $472.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award